Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.72 USD
Change Today +0.39 / 3.16%
Volume 5.3K
DPRX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barry Kagan

Director, Chairman of Audit & Finance Committee and Member of Nominating & Corporate Governance Committee, Dipexium Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
56--

Background*

Mr. Barry Kagan is the Founder of MBL Barry Corp. Prior to forming MBL in July 2013, Mr. Kagan joined CBM Capital Inc. in 2007 where he served as Executive Officer of Financial Operations. While at CBM, he was responsible for all financial, accounting, legal and compliance functions for domestic and offshore funds. From 2003 to 2007, Mr. Kagan served as the Chief Financial Officer of Bedford Oak Advisors, LLC While at Bedford, he was responsible for all financial, accounting, ...

Read Full Background

Corporate Headquarters*

61 Broadway
New York, New York 10006

United States

Phone: 212-269-2834
Fax: 212-269-2580

Board Members Memberships*

2012-Present
Director, Chairman of Audit & Finance Committee and Member of Nominating & Corporate Governance Committee

Education*

BBA 1980
Hofstra University School of Business

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DPRX:US $12.72 USD +0.39

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIPEXIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.